Ticagrelor monotherapy in PAtients treated with new-generation drug-eluting Stents for acute coronary Syndrome; T-PASS trial
Not Applicable
Recruiting
- Conditions
- Diseases of the circulatory system
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 2850
Inclusion Criteria
1. Patients =19 years old
2. Patients who received new generation sirolimus-eluting (Osiro® series) stent implantation for treating ACS, including acute MI and unstable angina
3. Provision of informed consent
Exclusion Criteria
1. Age> 80 years
2. Increased risk of bleeding, anemia, thrombocytopenia
3. A need for oral anticoagulation therapy
4. Pregnant women or women with potential childbearing
5. Life expectancy < 1 year
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method et clinical benefit (All-cause mortality, Myocardial infarction, stent thrombosis, major bleeding)
- Secondary Outcome Measures
Name Time Method Each components of net clinical benefit;Mortality (all-cause, cardiovascular);Bleeding (major and minor);Major adverse cardiac event